Look at EDSA, little company , halted for efficacy, stock

New Post Public Reply Private Reply Replies (1) Message Board
ohm20 stevo180 #106368
678
Quote:
Look at EDSA, little company , halted for efficacy, stock runs up 1 day and they are back in the dust again.


It was foreseeable as I said on 9/20 the day before it came back down to earth.

Quote:
Took a very quick look at the company low burn rate but also low cash on hand. Not a big problem there.

The run up was based on the press release of recovery for ECMO patients. Very small patient population and SCO was dexamethasone and IL-6 inhibitors which have shown little benefit in ECMO so easy to beat. I would put effectiveness on par with lenzilumab and I gave that a 50/50 chance of being approved.

What makes me wonder is out of 198 patients at the interim why 33 were on ECMO. The trial accepted patients that were level 3 (no oxygen) to level 6 (mechanical intubation or ECMO). With more available patients at the lower levels that's where you'd expect the preponderance of patients (as in CD12). The trial also excluded those who were on mechanical ventilation or ECMO for 5 days or longer further narrowing the potential patient pool. It looks like the deck was being stacked towards critical patients.

Of interest is that they released the interim for ECMO and critically ill but not the rest of the patient population. Critically ill mortality at interim is p = .15. Expected mortality for full phase 3 would be p = .75 still not statistically significant. That numbers weren't shown for the full patient population means the results were almost certainly worse.

With the small market cap there may be a further run up. But the FOMO based on the PR is overexuburant and overbought given the actual interim results. I would expect that realization will eventually dawn and there will be a pullback on the price. If I was in I would be monitoring the price like a hawk and sell on the start of a retraction. Better to lock down the profit on a nebulous upswing and potentially buy back in lower if you're confident of an approval.

Before I'd even hazard a guess to whether it's a long term hold I'd like to see the full data. If they are searching for an EUA they'd almost certainly have to change the protocol to ordinal scale 5, 6 only (high flow oxygen to ECMO).

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Meteor Education Bolsters CTE Reach with AET Labs Buy

Updated Category News Views 34

Meteor's Move: AET Labs Picked Up in CTE Plays You see, Meteor Education ain't sitting on its hands, that's for sure. They're out here hoarding strategic pieces like it's a chess match, snatching up AET Labs to bolster their already sturdy CTE playbook. No financial details spilled, but hell, that’s par for the course. This move plants them even more firmly in New...

Continue Reading
GNSS Simulator Market: $425M by 2031, Key Insight

Updated Category News Views 0

GNSS Simulator Market: Gadgets Meet Growth A market that's been quietly bubbling away on the back burner is about to boil over: The GNSS Simulator Market, pegged at a neat $424.6 million by 2031. Yeah, it might be niche, but those in the know can't get enough of these satellite-signal replicators. Why GNSS Simulators are Crushing It There's a bunch of reasons why GNSS...

Continue Reading
Ensign Group Faces Class Action Amid Stock Plummet

Updated Category News Views 117

Ensign Group's Recent Troubles Unraveled Let's set the scene: Ensign Group, once riding high at over $170 a share, finds itself knee-deep in allegations that'll make any investor squirm. Now, we're not just talking about a typical market fluctuation here – this is a real smackdown with an 8.2% drop, all thanks to some damning accusations. A Closer Look at Allegations...

Continue Reading
Endava Facing Securities Fraud Suit; Stocks Down 24%

Updated Category News Views 104

Endava Hits Rough Patch with Legal Battle Brewing So here we are, watching Endava plc struggle through legal quagmires and tumbling stock prices. Come September 21, 2026, news hit the street: Endava's CFO, Mark Thurston, found himself on administrative leave due to an investigation surrounding some shaky accounting practices. The Audit Committee raised a red flag, and...

Continue Reading
Xi Jinping's Vision for China's Financial Evolution

Updated Category News Views 115

Xi's Blueprint for Financial Strength Xi Jinping isn't just whistling Dixie when it comes to reshaping China's financial landscape. His vision is about more than pushing paper; it's about embedding honesty, prudence, and traditional values into the very DNA of China's financial sector. When he talks about enhancing both hard and soft power, he’s thinking wider than...

Continue Reading
D-Wave Faces Securities Fraud Class Action: Details Inside

Updated Category News Views 41

D-Wave Quantum Inc. in Hot Water Well folks, looks like D-Wave Quantum Inc. (NASDAQ: QBTS) is knee-deep in a securities fraud class action lawsuit. This ain't just another day in the quantum computing trenches. We've got Kessler Topaz Meltzer & Check, LLP, a big player in securities litigation, rallying the troops here—a clear sign that this case is packing some hefty...

Continue Reading
Cars24, Alba Cars Merge to Supercharge UAE Ventures

Updated Category News Views 57

An Unlikely Pair Turbocharging the Industry Sometimes, melding two distinct styles creates something extraordinary—like peanut butter and jelly or, in this case, Cars24 and Alba Cars. You get a combination of global tech platform savvy with premium retail chops. It’s kind of like blending the future with the tried-and-true past in automotive retail. Growing Pains or...

Continue Reading
BOC Group Sustains Leadership in Enterprise Architecture

Updated Category News Views 0

BOC Group's Continued Dominance It's not every day you see a company like BOC Group sticking to the Leader spot in Gartner's Magic Quadrant for six straight years. Anyone entrenched in enterprise architecture can recognize what a feat that is. Their tool, ADOIT, isn't just riding the AI trend—it’s steering it. It's like they've got this knack for fusing technology...

Continue Reading
Q-Ball Intelligence Launches Predictive Powerhouse

Updated Category News Views 0

Breaking Out in the Predictive AI Scene Q-Ball Intelligence doesn't just stroll onto the AI stage; they bulldoze in, backed by a beefy research legacy starting way back in 2007. Now, after 19 years marinating in the depths of predictive research—and putting some serious cash where their AI mouth is—they've officially launched as the new big thing in predictive...

Continue Reading
Differentia Bio's AI: Transforming Drug Development Dynamics

Updated Category News Views 0

The Future of Drug Development: AI's New Role When it comes to pharmaceutical R&D, Some outfits are playing pin the tail on the donkey, but Differentia Bio over here is sharpening the pin with some futuristic gadgetry. Yep, they're jazzing up the game with AI-powered digital twins, building lifelike disease environments that predict therapeutic outcomes with precision...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Partnership Launches Seamless ChromeOS Solution

Updated Category News Views 195

Promethean Teams Up with Google for Cutting-Edge Tech Promethean, a recognized name in educational technology and a brand within Mynd.ai, Inc. (NYSE American: MYND), has recently joined forces with Google to introduce an exciting new innovation in classroom technology. This partnership aims to simplify and enhance the user experience for educators and students through the...

Continue Reading
First Financial Bancorp Announces New Cash Dividend for Shareholders

Updated Category News Views 134

First Financial Bancorp Declares Quarterly Cash Dividend On a recent Tuesday, the board of directors of First Financial Bancorp. (NASDAQ: FFBC) made an announcement that will please shareholders. They declared a cash dividend of $0.24 per common share. This quarterly dividend showcases the company’s ongoing commitment to its investors and reflects its strong financial...

Continue Reading
Entegris Stock Review: Insider Moves and Market Cautions

Updated Category News Views 188

Insider Transactions Speak Volumes February 23 was a day of intrigue in the world of Entegris ( NASDAQ:ENTG). Linda LaGorga, the Senior Vice President, made waves when she exercised stock options worth a cool $572K. That's no small fry, folks—tracking insider activity like this can help guide your investment choices; plus, it might hint at bigger expectations from the...

Continue Reading
Innovative Partnership to Enhance Education for All Learners

Updated Category News Views 110

Enhancing Education Through Collaboration In a remarkable collaboration, Google has partnered with Korean startup Dot Inc. to revolutionize education for blind and low-vision learners globally. This alliance focuses on utilizing Dot Inc.'s innovative technology to create an inclusive learning environment accessible to all students. Creating Inclusive Digital Education The...

Continue Reading
Red Cat's Teal Drones Earns Prestigious AS9100 Aerospace Certification

Updated Category News Views 137

Red Cat Achieves Prestigious Aerospace Certification Red Cat Holdings, Inc. (Nasdaq: RCAT), a forward-thinking drone technology company that creates innovative robotic systems for various applications, has reached a remarkable milestone. Its subsidiary, Teal Drones, has recently been awarded the AS9100 certification, signifying its commitment to excellence in the...

Continue Reading